fluorescein has been researched along with Cancer of Ovary in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Wang, J; Yan, B; Zhao, L | 1 |
Bugno, J; Burdette, JE; Hong, S; Lantvit, DD; Modi, DA; Sunoqrot, S | 1 |
Fu, Y; He, Q; Liu, J; Song, QG; Yuan, WM; Zhang, ZR | 1 |
Gmitro, AF; Hatch, KD; Rouse, AR; Tanbakuchi, AA; Udovich, JA | 1 |
Fowers, KD; Kopeček, J | 1 |
Goodman, M; Holzer, AK; Howell, SB; Katano, K; Larson, BJ; Naerdemann, W; Safaei, R; Samimi, G; Tomioka, M | 1 |
Bater, AJ; Deeley, TJ; Kerby, IJ; Pritchard, JA; Siddall, JE; Sutherland, WH | 1 |
Dvorak, HF; Herzberg, KT; Masse, EM; Nagy, JA; Zientara, GP | 1 |
8 other study(ies) available for fluorescein and Cancer of Ovary
Article | Year |
---|---|
Indicator Displacement Assay Inside Dye-Functionalized Covalent Organic Frameworks for Ultrasensitive Monitoring of Sialic Acid, an Ovarian Cancer Biomarker.
Topics: Animals; Biomarkers, Tumor; Female; Fluorescein; Fluorescent Dyes; Humans; Metal-Organic Frameworks; N-Acetylneuraminic Acid; Ovarian Neoplasms; Sensitivity and Specificity; Spectrometry, Fluorescence | 2020 |
Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Survival; Dendrimers; Drug Carriers; Female; Fluorescein; Follicle Stimulating Hormone; Humans; Immobilized Proteins; Inhibitor of Apoptosis Proteins; Mice; Mice, Inbred BALB C; Nanostructures; Ovarian Neoplasms; Ovary; Protein Structure, Tertiary; Survivin | 2014 |
LHRHa aided liposomes targeting to human ovarian tumor cells: preparation and cellular uptake.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cholesterol Esters; Chromatography, High Pressure Liquid; Docetaxel; Drug Compounding; Drug Delivery Systems; Electrochemistry; Female; Fluorescein; Fluorescence; Humans; Liposomes; Luteinizing Hormone; Magnetic Resonance Spectroscopy; Ovarian Neoplasms; Reference Standards; Regression Analysis; Taxoids | 2008 |
In vivo imaging of ovarian tissue using a novel confocal microlaparoscope.
Topics: Acridine Orange; Equipment Design; Female; Fluorescein; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; Laparoscopes; Ovarian Neoplasms; Ovary; Pilot Projects | 2010 |
Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.
Topics: Acrylic Resins; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Cell Line, Tumor; Cell Membrane; Cell Survival; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Endocytosis; Female; Fluorescein; Humans; Immunoconjugates; Ovarian Neoplasms | 2012 |
Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells.
Topics: Adenosine Triphosphatases; Androstadienes; Antineoplastic Agents; Biological Transport; Brefeldin A; Cation Transport Proteins; Cell Nucleus; Cisplatin; Contrast Media; Copper; Copper-Transporting ATPases; Cytoplasm; Female; Fluorescein; Golgi Apparatus; Humans; Isoquinolines; Lysosomes; Microscopy, Confocal; Microscopy, Fluorescence; Ovarian Neoplasms; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Recombinant Fusion Proteins; Subcellular Fractions; Sulfonamides; Tumor Cells, Cultured; Wortmannin | 2005 |
Fluorescent probes for the detection of malignant disease.
Topics: 1-Naphthylamine; Carcinoma; Cell Separation; Female; Flow Cytometry; Fluorescein; Fluoresceins; Humans; Lymphocyte Activation; Lymphocytes; Neoplasms; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1983 |
Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice.
Topics: Adenocarcinoma; Animals; Ascites; Biological Transport; Breast Neoplasms; Capillary Permeability; Dextrans; Female; Fluorescein; Fluoresceins; Mice; Molecular Weight; Ovarian Neoplasms; Peritoneal Cavity; Peritoneum; Serotonin | 1989 |